Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subdose esketamine for low-opioid general anesthesia in elderly lumbar surgery
ChiCTR2200066896Phase 4Not yet recruiting
- Sponsor
- Hefei Binhu Hospital
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Perioperative cardiovascular instability (PCVI) and surgical stress (3 arms), sponsored by Hefei Binhu Hospital. Primary endpoints: Blood pressure and Inflammatory factors. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Perioperative cardiovascular instability (PCVI)surgical stress
Beyond the preview
Go deeper on ChiCTR2200066896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066896.